206 related articles for article (PubMed ID: 24086435)
1. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins.
Park JW; Shin MK; Pitot HC; Lambert PF
PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435
[TBL] [Abstract][Full Text] [Related]
2. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
Park JW; Shin MK; Lambert PF
Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
[TBL] [Abstract][Full Text] [Related]
3. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
4. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
5. The fanconi anemia pathway limits human papillomavirus replication.
Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
Song S; Gulliver GA; Lambert PF
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.
Khanal S; Galloway DA
PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369
[TBL] [Abstract][Full Text] [Related]
9. Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine.
Tseng SH; Liu L; Peng S; Kim J; Ferrall L; Hung CF; Wu T-
J Biomed Sci; 2021 Sep; 28(1):63. PubMed ID: 34517865
[TBL] [Abstract][Full Text] [Related]
10. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
11. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
13. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
Carcinogenesis; 2015 Nov; 36(11):1397-406. PubMed ID: 26354779
[TBL] [Abstract][Full Text] [Related]
14. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.
Simonson SJ; Difilippantonio MJ; Lambert PF
Cancer Res; 2005 Sep; 65(18):8266-73. PubMed ID: 16166303
[TBL] [Abstract][Full Text] [Related]
15. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.
Wieking BG; Vermeer DW; Spanos WC; Lee KM; Vermeer P; Lee WT; Xu Y; Gabitzsch ES; Balcaitis S; Balint JP; Jones FR; Lee JH
Cancer Gene Ther; 2012 Oct; 19(10):667-74. PubMed ID: 22918471
[TBL] [Abstract][Full Text] [Related]
16. Dominant role of HPV16 E7 in anal carcinogenesis.
Thomas MK; Pitot HC; Liem A; Lambert PF
Virology; 2011 Dec; 421(2):114-8. PubMed ID: 21999991
[TBL] [Abstract][Full Text] [Related]
17. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.
Park JW; Nickel KP; Torres AD; Lee D; Lambert PF; Kimple RJ
Radiother Oncol; 2014 Dec; 113(3):337-44. PubMed ID: 25216575
[TBL] [Abstract][Full Text] [Related]
19. Malignant Transformation of Fanconi Anemia Complementation Group D2-deficient (
Zhang X; Fisher R; Shields D; Hou W; Franicola D; Wang H; Epperly MW; Rigatti L; Greenberger JS
In Vivo; 2019; 33(2):303-311. PubMed ID: 30804107
[TBL] [Abstract][Full Text] [Related]
20. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
